Why Does LH Change Across Your Cycle?

Why Does LH Change Across Your Cycle?

LH rises and falls in a predictable pattern tied to estrogen signaling from your ovaries — a mid-cycle surge triggers ovulation, after which LH drops sharply. The main caveat: this pattern breaks down in conditions like PCOS, where LH is chronically elevated, or in perimenopause, where the surge becomes erratic. If you're not cycling, LH behaves differently entirely.

---

What Is LH and Why Does It Matter?

Luteinizing hormone (LH) is a glycoprotein released by the anterior pituitary gland in response to gonadotropin-releasing hormone (GnRH) from the hypothalamus. Its primary job in people with ovaries is to trigger ovulation and stimulate the corpus luteum to produce progesterone after ovulation occurs.

LH doesn't work in isolation. It works in concert with follicle-stimulating hormone (FSH), estradiol, and progesterone in a tightly choreographed feedback loop. Each hormone rises and falls in sequence — and LH is often the conductor of the most critical moment: the release of a mature egg.

Understanding LH across your cycle is useful not just for fertility tracking but for overall hormonal health. Elevated or suppressed LH at the wrong phase of your cycle can signal disruptions in your hypothalamic-pituitary-ovarian (HPO) axis, which affects everything from mood to metabolism to bone density. The GnRH pulse generator in the hypothalamus is itself regulated by kisspeptin neurons in the arcuate nucleus — these neurons integrate signals from estrogen, progesterone, body weight, and metabolic status before determining how often the pituitary gets a GnRH pulse. This means that LH is genuinely a readout of your metabolic and reproductive health simultaneously, not just a fertility marker.

---

The LH Curve: Phase by Phase

Follicular Phase (Days 1–13, approximately)

During the early follicular phase, LH is relatively low — typically in the range of 1–7 IU/L. The pituitary is releasing LH in small, pulsatile bursts controlled by GnRH pulses from the hypothalamus. At this stage, the developing follicles in your ovaries are responding primarily to FSH, which is driving follicle recruitment and growth.

As the dominant follicle matures and begins secreting larger amounts of estradiol, something counterintuitive happens: instead of suppressing LH (as estrogen does at lower levels), high estradiol concentrations flip into a positive feedback mechanism. This triggers the hypothalamus to increase GnRH pulsatility and the pituitary to surge LH. The threshold for this positive feedback is approximately 200 pg/mL of estradiol sustained for at least 50 hours — below that, the negative feedback loop dominates and LH stays suppressed. (Messinis, Human Reproduction Update 2006; PMID: 16291875)

The LH Surge (Approximately Day 12–14)

The LH surge is the most dramatic hormonal event of the cycle. LH levels can rise anywhere from 3- to 10-fold above baseline, often reaching 15–60 IU/L, and the surge typically lasts 24–48 hours. This spike is what triggers the final maturation of the egg and its release from the follicle — ovulation.

The surge begins approximately 34–36 hours before ovulation, which is why LH-based ovulation predictor kits (OPKs) are so useful for timing. Once the egg is released, LH drops rapidly. Mechanistically, the LH surge activates resumption of meiosis in the oocyte and induces expression of proteolytic enzymes in the follicle wall — it is not just a timing signal but an active driver of follicular rupture. A blunted or short surge (lasting fewer than 16 hours) has been associated with luteinized unruptured follicle syndrome, where the follicle fails to release the egg despite apparent hormonal cycling.

If you want to understand when to test for LH — or any hormone — timing relative to ovulation matters enormously. Similarly, when in your cycle you test estradiol changes the reference ranges your results should be compared against.

Luteal Phase (Days 15–28, approximately)

After ovulation, the ruptured follicle transforms into the corpus luteum, which now becomes the dominant secretor of progesterone. LH levels fall substantially and remain relatively low — typically 1–11 IU/L — throughout the luteal phase. LH continues to support the corpus luteum in the early luteal phase, but if no pregnancy occurs, the corpus luteum degrades, progesterone drops, and menstruation begins.

The corpus luteum is acutely sensitive to the amplitude of LH pulses in the early luteal phase — small-amplitude pulses are sufficient to maintain progesterone output for the first several days, but pulse frequency matters more as the luteal phase progresses. A drop in LH pulse frequency during mid-luteal phase is one mechanism behind luteal phase defect, a pattern where progesterone is insufficient even though ovulation occurred.

The rise and fall of progesterone across your cycle mirrors this post-ovulatory LH pattern — which is why a low luteal-phase progesterone reading often points back to an inadequate LH surge or poor follicular development.

---

What Disrupts Normal LH Patterns?

PCOS and Elevated LH

In polycystic ovary syndrome (PCOS), GnRH pulse frequency increases abnormally, causing LH to be secreted in higher-amplitude pulses throughout the cycle. Many women with PCOS have an elevated LH:FSH ratio (often greater than 2:1 or 3:1), which promotes androgen production over healthy follicle maturation. This is why ovulation is irregular or absent in PCOS despite the follicles attempting to develop. (Balen et al., Human Reproduction 1995; PMID: 7782438)

The excess LH drives theca cell androgen synthesis via the LH receptor signaling cascade — elevated intracellular cAMP upregulates CYP17A1 enzyme activity, increasing testosterone and androstenedione output. This is distinct from the insulin-mediated androgen pathway, meaning some women with PCOS have both mechanisms operating simultaneously, which is why a single intervention rarely normalizes LH alone.

If your symptoms seem to shift week to week, understanding why PCOS symptoms change across the cycle can help contextualize why LH-driven androgen fluctuations feel inconsistent.

Perimenopause and Erratic LH

As ovarian reserve declines during perimenopause, the remaining follicles respond poorly to FSH, and estradiol levels become variable. The pituitary compensates by secreting more FSH and LH in an attempt to drive follicle development — but because the feedback is now erratic, LH surges can be mistimed, blunted, or exaggerated. This is one reason why perimenopause symptoms are so unpredictable week to week.

You can explore this hormonal instability further in why perimenopause symptoms change week to week, which covers how shifting gonadotropin levels drive the variability many women experience.

Hypothalamic Amenorrhea

In hypothalamic amenorrhea — often caused by extreme energy restriction, overtraining, or chronic psychological stress — GnRH pulse frequency slows dramatically. The result is suppressed LH (often below 1–2 IU/L), no LH surge, and absent or infrequent periods. This is a protective mechanism, but it carries significant downstream risks including bone loss from low estrogen. Research using frequent blood sampling has shown that women with functional hypothalamic amenorrhea may have GnRH pulses occurring only every 3–4 hours rather than the normal 60–90 minute interval — a pattern that selectively suppresses LH more than FSH. (Gordon et al., Journal of Clinical Endocrinology & Metabolism 2017; PMID: 28359099)

Elevated Prolactin

Hyperprolactinemia suppresses GnRH pulsatility, which in turn reduces LH. This is why pituitary adenomas or medications that raise prolactin — including some antipsychotics, antidepressants, and metoclopramide — can disrupt ovulation and cycle regularity even when ovarian tissue is healthy. Prolactin suppresses kisspeptin neurons directly, interrupting the upstream signal that drives GnRH release. Even modestly elevated prolactin (in the 30–50 ng/mL range, not just frank hyperprolactinemia above 100) can be sufficient to blunt the LH surge in some individuals.

---

LH Reference Ranges and How to Interpret Them

LH values are only interpretable in the context of your cycle phase. A value of 30 IU/L is normal during the mid-cycle surge; the same value in the early follicular phase suggests a problem. This is why cycle-day labeling on lab results matters, and why testing LH as a single fasted draw without knowing your cycle phase produces limited information.

Note that postmenopausal LH is persistently elevated — not because a surge is occurring, but because the pituitary is no longer receiving estradiol feedback. This is clinically distinct from the mid-cycle surge. When interpreting a borderline result, FSH should always be assessed alongside LH: an elevated LH with a normal FSH points more toward PCOS; an elevated FSH with elevated LH in a reproductive-age woman is more suggestive of diminished ovarian reserve or premature ovarian insufficiency.

The relationship between LH and SHBG across your cycle is also relevant: estrogen drives SHBG production, and the hormonal shifts that accompany the LH surge have downstream effects on how androgens are bound and available in your blood.

---

Does Nutrition Affect LH Regulation?

This is an area of active research. The HPO axis is highly sensitive to metabolic signals, including insulin, leptin, and energy availability. Several nutrients have been studied for their effects on LH and ovulatory function:

Inositol (myo-inositol and D-chiro-inositol): In women with PCOS, inositol supplementation has been shown to improve insulin sensitivity and reduce LH:FSH ratios, partly by reducing hyperinsulinemia-driven androgen production. A randomized trial found myo-inositol 4g/day improved ovulation rates and reduced LH in PCOS patients over 12–16 weeks. (Gerli et al., Gynecological Endocrinology 2007; PMID: 17454643)

Omega-3 fatty acids: EPA and DHA have anti-inflammatory effects that may support HPO axis function by reducing prostaglandin E2-driven disruption of GnRH signaling. In a 2012 randomized trial, omega-3 supplementation reduced testosterone and LH:FSH ratio in women with PCOS over 8 weeks. (Vargas et al., Journal of Obstetrics and Gynaecology 2011; doi.org/10.3109/01443615.2011.570849)

Zinc: Zinc is a cofactor for GnRH receptors and pituitary gonadotropin release. Deficiency is associated with blunted LH responses. Zinc also inhibits aromatase activity at supraphysiological concentrations, though at dietary and supplemental doses its primary hormonal role is in supporting receptor sensitivity rather than enzyme inhibition. (Prasad, Journal of Trace Elements in Medicine and Biology 2012; PMID: 22464945)

Vitamin D: Low vitamin D status is associated with higher LH:FSH ratios and increased androgen levels in PCOS cohorts. Vitamin D receptors are expressed in the ovary and pituitary, suggesting a direct role in gonadotropin regulation. A 2011 observational study in 206 PCOS women found that every 10 nmol/L increase in 25-OH vitamin D was associated with a 0.08 IU/L reduction in LH, an effect size that was small but statistically significant across the cohort. (Wehr et al., European Journal of Endocrinology 2011; PMID: 21415144)

Magnesium: Magnesium deficiency impairs insulin signaling and increases inflammatory cytokine activity — both of which can elevate GnRH pulse frequency indirectly. Magnesium supplementation at 300–400mg/day has been studied for PMS severity and cycle regularity, though direct LH data are limited. Its role in HPO support is likely indirect, operating through improved insulin sensitivity and reduced HPA axis reactivity rather than direct gonadotropin modulation.

---

What This Means for Your Formula

For most people reading about LH patterns, the underlying goal is either optimizing ovulatory function, understanding hormonal disruptions, or supporting the HPO axis during perimenopause. Ones approaches this from a data-driven perspective: rather than guessing which nutrients your HPO axis needs, the Ones AI analyzes your lab results and wearable data to identify gaps relevant to your specific hormonal profile.

If your labs suggest patterns consistent with low-grade inflammation, insulin dysregulation, or micronutrient insufficiency affecting cycle regularity, the formula Ones builds may include:

• Omega-3 (EPA/DHA): Dosed at clinical ranges shown in ovulatory and anti-inflammatory trials, supporting the signaling environment the HPO axis operates in. The anti-inflammatory mechanism is particularly relevant if your pattern shows elevated androgens alongside LH dysregulation.
• Zinc: Included at doses that address documented deficiency — zinc's role as a GnRH receptor cofactor means it's directly relevant to pituitary function, not just immune health. Ones sources zinc as a highly bioavailable chelate form to minimize GI interference.
• Vitamin D3 + K2 (MK-7): Ones pairs D3 with MK-7 for cofactor synergy; D3 specifically has evidence in HPO axis regulation and LH:FSH ratios in women with insufficiency. The dose in your formula reflects your actual 25-OH vitamin D level from bloodwork — not a generic 1,000 IU default.

If your pattern instead points to adrenal stress load or HPA axis dysregulation affecting HPO function — a common interplay in which elevated cortisol suppresses kisspeptin neurons and blunts the LH surge — the Ones AI may also include Adrenal Support from its System Blends, which addresses the cortisol-to-GnRH interference pathway. Unlike picking supplements off a shelf, the formula is calibrated to your findings; someone with a documented LH surge but low luteal progesterone gets a different combination than someone with anovulatory cycles and a chronically elevated LH:FSH ratio.

---

Key Takeaways

• LH follows a precise curve across the cycle: low during the follicular phase, surging 3- to 10-fold at mid-cycle to trigger ovulation, then dropping through the luteal phase.
• The surge mechanism depends on a positive estradiol feedback threshold — roughly 200 pg/mL sustained for 50+ hours — that flips the usual negative feedback loop.
• PCOS raises LH via excessive GnRH pulse frequency; hypothalamic amenorrhea suppresses LH by slowing those pulses; both are disruptions of the same upstream kisspeptin-GnRH mechanism.
• A single LH lab value is nearly uninterpretable without knowing your cycle phase — always test in context and always assess LH alongside FSH.
• Nutrition genuinely affects LH regulation: inositol, omega-3, zinc, and vitamin D all have trial evidence for LH:FSH ratio normalization, particularly in PCOS.
• Personalized formulas that match dose to your actual labs — not population averages — are the most direct route from identifying an LH disruption pattern to supporting the underlying cause.